Trade

with

StemCells Inc
(NASDAQ: STEM)
AdChoices
1.19
+0.03
+2.15%
After Hours :
1.15
-0.04
-3.36%

Open

1.19

Previous Close

1.17

Volume (Avg)

1.48M (752.73k)

Day's Range

1.17-1.25

52Wk Range

1.02-2.43

Market Cap.

81.68M

Dividend Rate ( Yield )

-

Beta

1.64

Shares Outstanding

68.64M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 1.20M

    • Net Income

    • -26.44M

    • Market Cap.

    • 81.68M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -2,779.98

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.64

    • Forward P/E

    • -1.86

    • Price/Sales

    • 50.51

    • Price/Book Value

    • -32.15

    • Price/Cash flow

    • -2.26

      • EBITDA

      • -24.21M

      • Return on Capital %

      • -108.60

      • Return on Equity %

      • -1,090.59

      • Return on Assets %

      • -108.60

      • Book Value/Share

      • -0.04

      • Shares Outstanding

      • 68.64M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 5.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.64

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -14.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 39.02

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 72.31

            • 82.75

            • Pre-Tax Margin

            • -2,779.98

            • 39.38

            • Net Profit Margin

            • -2,779.98

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 79.70

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -2,103.70

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 2.28

              • 2.92

              • Quick Ratio

              • 2.18

              • 2.35

              • Interest Coverage

              • -21.78

              • 38.02

              • Leverage Ratio

              • -

              • 2.21

              • Book Value/Share

              • -0.04

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.82

                • 196.08

                • P/E Ratio 5-Year High

                • -24.24

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.90

                • 124.82

                • Price/Sales Ratio

                • 50.51

                • 9.12

                • Price/Book Value

                • -32.15

                • 8.26

                • Price/Cash Flow Ratio

                • -2.26

                • 47.39

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -1,090.59

                    (-157.90)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -108.60

                    (-74.70)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -208.73

                    (-142.90)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.04

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -28.61M
                  Operating Margin
                  -2,377.31
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.26
                  Ownership

                  Institutional Ownership

                  25.31%

                  Top 10 Institutions

                  29.32%

                  Mutual Fund Ownership

                  3.22%

                  Float

                  98.40%

                  5% / Insider Ownership

                  5.35%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    968,924

                  • 0.00

                  • 1.41

                  • Vanguard Extended Market Index Fund

                  •  

                    538,913

                  • 10.11

                  • 0.79

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    234,471

                  • 41.55

                  • 0.34

                  • iShares Micro-Cap

                  •  

                    172,998

                  • 1.28

                  • 0.23

                  • EB DL Non-SL Market Completion Fund

                  •  

                    85,953

                  • 300.36

                  • 0.15

                  • Fidelity Spartan® Total Market Idx Fund

                  •  

                    41,468

                  • 0.00

                  • 0.06

                  • Vanguard Instl Total Stock Market Index

                  •  

                    27,652

                  • 0.00

                  • 0.04

                  • Mellon Cap Market Completion Strategy

                  •  

                    24,203

                  • 935.64

                  • 0.04

                  • Master Extended Market Index Series

                  •  

                    19,530

                  • 0.00

                  • 0.03

                  • USAA Extended Market Index Fund

                  •  

                    19,522

                  • -0.04

                  • 0.03

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • BlackRock Fund Advisors

                  •  

                    2,896,788

                  • +3.61%

                  • 5.08

                  • Vanguard Group, Inc.

                  •  

                    1,006,487

                  • +3.92%

                  • 1.77

                  • Bourgeon Capital Management LLC

                  •  

                    272,102

                  • +20.35%

                  • 0.48

                  • Perceptive Advisors LLC

                  •  

                    271,600

                  • 0.00%

                  • 0.48

                  • Geode Capital Management, LLC

                  •  

                    209,025

                  • 0.00%

                  • 0.37

                  • JANE STREET GROUP, LLC

                  •  

                    133,581

                  • +145.97%

                  • 0.23

                  • BNY Mellon Asset Management Ltd.

                  •  

                    113,301

                  • +209.68%

                  • 0.20

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Slow Growth

                  Style

                  Small Core

                  StemCells, Inc. is a Delaware Corporation incorporated in 1988. The Company is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry. It is f...moreocused on cellular medicine, or the use of stem and progenitor cells as the basis for novel therapeutics and therapies, and enabling technologies for stem cell research, or the use of cells and related technologies to enable stem cell-based research and drug discovery and development. The Company’s primary research and development efforts are focused on cellular medicine, where it seeks to identify and develop stem and progenitor cells as potential therapeutic agents. It currently has two therapeutic product development programs; its CNS Program, which is developing appl...moreications for HuCNS-SC cells, its proprietary human neural stem cell product candidate, and its Liver Program, which is developing applications for its proprietary human liver engrafting cells. It currently markets various proprietary cell culture products under the SC Proven brand, including iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27. The Company’s primary strategy is to identify multiple types of human stem and progenitor cells with therapeutic and commercial importance, to develop techniques and processes to purify these cells for direct transplant and to expand and bank these cells, to advance these cells into clinical development and ultimately, to commercialize them as cell-based therapeutic products. The Company’s research and development activities and the future manufacturing and marketing of its potential therapeutic products are, and would continue to be, subject to regulation for safety and efficacy by numerous governmental authorities in the United States and other countries.lessless

                  Key People

                  Martin M. Mcglynn

                  CEO/CEO, Subsidiary/Director/President/President, Subsidiary

                  Dr. John J. Schwartz,PhD

                  Chairman of the Board/Director

                  Mr. Gregory T. Schiffman

                  CFO/Executive VP, Divisional

                  Dr. Ann Tsukamoto,PhD

                  Executive VP, Divisional

                  Dr. Nicki Vasquez

                  Vice President, Divisional

                  • StemCells Inc

                  • 7707 Gateway Boulevard

                  • Newark, CA 94560

                  • USA.Map

                  • Phone: +1 510 456-4000

                  • Fax: +1 510 456-4001

                  • stemcellsinc.com

                  Incorporated

                  1988

                  Employees

                  58

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: